Please join ACT for our Annual Research Update on May 22, 2024 at 3:00pm Central Time. Select research partners will be sharing the latest developments in microbiota transplant therapy in their respective fields of study with opportunities for questions from participants. This zoom webinar is complimentary, to register and reserve your spot, click the "Register Now" button.
Event Presenters:
Alexander Khoruts, M.D., Director of the Microbiota Therapeutics Program, University of Minnesota
One of the founding investigators of Microbiota Transplant Therapy (MTT), Dr. Khoruts directs the only academic program designing and providing microbiota therapeutics to clinical trials and C. difficile patients throughout the nation.
James Adams, Ph.D., Director of the Autism/Asperger's Research Program, Arizona State University
Rosa Krajmalnik-Brown, Ph.D., Director of the Biodesign Center for Health Through Microbiomes, Arizona State University
Dr. Adams and Dr. Krajmalnik-Brown are pioneering gut microbiome research with Autism and Pitt Hopkins Syndrome patients.
Armin Rashidi, M.D., Ph.D., Hematology & Oncology, Fred Hutchison Cancer Center
Dr. Rashidi is investigating the impact of microbial restoration on patient outcomes after intensive cancer therapy.
Cyrus Jahansouz, M.D., Colon & Rectal Surgery, University of Minnesota
Dr. Jahansouz's research focuses on patient success post-colorectal surgery and minimizing the risk and prevalence of Anastomotic Leak through restoring patient gut bacteria composition.
Noah Goldfarb, M.D., Dermatology, University of Minnesota
Dr. Goldfarb supports patients with Hidradenitis Suppurativa, a chronic and painful skin condition, through research with microbiota therapeutics.
Amanda Kabage, Research Program Manager & Regulatory Specialist, University of Minnesota
Amanda guides patients with Autism and their families through the individual clinical trial process and has insight into their personal experiences receiving Microbiota Transplant Therapy.
Donate Now
Your donation is saving lives! No act of generosity is too small to make a difference.
Your contribution towards Achieving Cures Together allows patients suffering from recurrent C. difficile infections to receive treatment with a 98% success rate and pushes groundbreaking research forward. With your support, clinical trials are underway targeting conditions including Autism, Ulcerative Colitis, Cancer recovery, Crohn's Disease, Advanced Liver Disease and more. Thank you for your partnership and for your gift of healing and hope.
Hosted By ACT
Share With Others
